Vor Bio to Participate in the 46th Annual TD Cowen Health Care Conference
BOSTON, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it will be presenting and hosting 1x1 investor meetings at the 46th Annual TD Cowen Health Care Conference in Boston, MA.
Presentation: Monday, March 2, 2026 at 9:50am – 10:20 am ET
Location: Regis
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Wirex Launches Navoka, an AI Agent That Pays From Its Own Bank Account and Card
TeraGo 3Q Loss C$3.7M >TGO.T
Hudbay cuts cost outlook as Copper Mountain improves
MediaAlpha: Repurchased Shrs Will Be Canceled and Retired >MAX
Crypto prices
More
